SEC Tracker
Get the app
EXAS · As filed with the SEC

Exact Sciences balance sheet, by fiscal year

The statement as Exact Sciences presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousandsFY2025
Dec 31, 2025		FY2024
Dec 31, 2024		FY2023
Dec 31, 2023		FY2021
Dec 31, 2022
ASSETS
Current assets:
Cash and cash equivalents955,996600,889605,378242,493
Marketable securities8,715437,137172,266389,564
Accounts receivable, net298,653248,968203,623158,043
Inventory166,201162,383127,475118,259
Prepaid expenses and other current assets126,284122,04685,62773,898
Total current assets1,555,8491,571,4231,194,369982,257
Long-term assets:
Property, plant and equipment, net708,664693,673698,354684,756
Operating lease right-of-use assets122,332116,952143,708167,003
Goodwill2,368,0482,366,6762,367,1202,346,040
Intangible assets, net919,9251,009,6931,890,3961,956,240
Other long-term assets, net185,811169,722177,38790,577
Total assets5,860,6295,928,1396,471,3346,226,873
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable175,86889,57278,81674,916
Accrued liabilities416,473328,292341,683299,216
Operating lease liabilities, current portion33,59127,40529,37928,366
Other current liabilities15,22037,76514,82310,249
Loans Payable, Current—050,000—
Convertible Notes Payable, Current0249,153——
Total current liabilities641,152732,187514,701412,747
Convertible notes, net, less current portion2,327,1772,321,0672,314,2762,186,106
Long-term debt, less current portion——050,000
Other long-term liabilities329,317315,503335,982352,459
Operating lease liabilities, less current portion161,931157,133161,070182,399
Total liabilities3,459,5773,525,8903,326,0293,183,711
Stockholders’ equity:
Preferred stock, $0.01 par value Authorized—5,000,000 shares issued and outstanding—no shares at December 31, 2025 and December 31, 20240000
Common stock, $0.01 par value Authorized—400,000,000 shares issued and outstanding—190,802,322 and 185,616,438 shares at December 31, 2025 and December 31, 20241,9091,8571,8151,780
Additional paid-in capital7,102,7666,899,3686,611,2376,311,644
Accumulated other comprehensive income (loss)2,358(944)1,428(5,236)
Accumulated deficit(4,705,981)(4,498,032)(3,469,175)(3,265,026)
Total stockholders’ equity2,401,0522,402,2493,145,3053,043,162
Total liabilities and stockholders’ equity5,860,6295,928,1396,471,3346,226,873

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.